BAFF antibody (AA 254-269)
Quick Overview for BAFF antibody (AA 254-269) (ABIN319035)
Target
See all BAFF (TNFSF13B) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 254-269
-
Specificity
- This antibody recognises CD257 (also known as BLyS, BAFF, TALL-1 and THANK).
-
Purification
- Purified
-
Immunogen
- Peptide corresponding to amino acids 254-269 of human CD257 (BAFF).
-
Isotype
- IgG
-
-
-
-
Application Notes
-
Western Blot: 0.25g/mL - 1g/mL.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. -
Restrictions
- For Research Use only
-
-
-
Concentration
- 0.5 mg/mL
-
Buffer
- Phosphate buffered saline containing 0.02 % Sodium Azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handling Advice
- Avoid repeated freezing and thawing.
-
Storage
- 4 °C/-20 °C
-
Storage Comment
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- BAFF (TNFSF13B) (Tumor Necrosis Factor (Ligand) Superfamily, Member 13b (TNFSF13B))
-
Alternative Name
- CD257 / BAFF
-
Background
- CD257 is a novel member of the tumor necrosis factor (TNF) superfamily. CD257 and its receptor TACI/BCMA are involved in the development of autoimmune diseases. CD257 has been shown to activate NFkB and JNK (c-jun N-terminal kinase) and induce apoptosis.Synonyms: B cell-activating factor, B lymphocyte stimulator, BAFF, BLYS, Dendritic cell-derived TNF-like molecule, TALL1, TNF- and APOL-related leukocyte expressed ligand 1, TNFSF13B, TNFSF20, Tumor necrosis factor ligand superfamily member 13B, ZTNF4
-
Gene ID
- 10673
-
NCBI Accession
- NP_001139117
-
UniProt
- Q9Y275
-
Pathways
- NF-kappaB Signaling, Production of Molecular Mediator of Immune Response
Target
-